Improve your knowledge in Pediatric Dermatology through this program, where you will find the best teaching material with real clinical cases. Learn here about the latest advances in the specialty to be able to provide quality medical care"

At the diagnostic level, the advances that are being made in the knowledge of the etiology of each of the diseases, emerging pathologies, new imaging and laboratory techniques, and diagnostic algorithms that are in continuous renewal, requires us to keep our knowledge of Pediatric Dermatology and other related specialties (Pediatrics, Genetics, Radiology, etc.) continuously updated.

At the therapeutic level, the appearance of new drugs and techniques for already known pathologies and the need for new strategies for the integral approach of the patient, makes it more than necessary to know all this arsenal of resources that we can, if necessary, use to attend our patients with the maximum guarantee.

The program is designed to provide an online education equivalent to 1,500 hours of study and all the theoretical and practical knowledge is presented through high quality multimedia content, analysis of clinical cases prepared by experts, master classes and video techniques that allow the exchange of knowledge and experience, maintaining and updating the educational level of its members, creating protocols for action and disseminating the most important developments in the specialty. With online education, students can organize their time and pace of learning, adapting it to their schedules, in addition to being able to access the contents from any computer or mobile device.

Up to date knowledge through the Master's Degree program in Pediatric Dermatology"

This Master's Degree in Pediatric Dermatology contains the most complete and up to date scientific program on the market. The most important features include:

• More than 75 clinical cases presented by experts in pediatric dermatology 
• The graphic, schematic, and practical contents with which they are created provide scientific and practical information on the disciplines that are essential for professional practice
• Diagnostic-therapeutic developments on assessment, diagnosis and treatment in pediatric dermatology
• It contains practical exercises where the self-evaluation process can be carried out to improve learning
• Iconography of clinical and diagnostic imaging tests
• An algorithm-based interactive learning system for decision-making in the clinical situations presented throughout the course
• With special emphasis on evidence-based medicine and research methodologies in pediatric dermatology
• All of this will be complemented by theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

This Master's Degree is the best investment you can make for two reasons: you will obtain a qualification accredited by TECH Global University, and you will acquire the best and most up-to-date education in Pediatric DermatologyPediatric Dermatology

The teaching staff includes professionals from the field of Pediatric Dermatology, who bring their experience to this training program, as well as renowned specialists from leading scientific societies.

The multimedia content developed with the latest educational technology will provide students with situated and contextual learning, i.e., a simulated environment that will provide immersive learning programmed to train in real situations.

This program is designed around Problem-Based Learning, whereby the physician must try to solve the different professional practice situations that arise during the course For this purpose, the physician will be assisted by an innovative interactive video system created by renowned and experienced experts in the field of Pediatric Dermatology with extensive teaching experience.

It includes clinical cases to bring the development of the Master's Degree as close as possible to the reality of medical practice"

Take the opportunity to learn about the latest advances in this field and apply it to your daily practice"

The structure of the contents has been designed by a team of professionals from the best hospitals and universities in the country, who are aware of the relevance of up-to-date training to be able to intervene in the prevention, diagnosis, and treatment of dermatological pathology in pediatric patients, and who are committed to quality teaching through new educational technologies.

This Master's Degree in Pediatric Dermatology contains the most complete and up-to-date scientific program on the market”

Module 1. Review of Congenital and Neonatal Skin Pathology

1.1. Physiological Skin Changes Neonates

1.1.1. Neonatal Skin
1.1.2. Physiological Vascular Changes
1.1.3. Physiological Pigmentary Changes
1.1.4. Lanugo and Physiological Changes of the Hair

1.2. Benign and Transient Skin and Mucous Membranes Lesions

1.2.1. Miliums
1.2.2. Bohn’s Nodules and Epstein’s Pearls
1.2.3. Congenital Epulis and Neonatal Teeth
1.2.4. Suction Calluses
1.2.5. Sebaceous Hyperplasia
1.2.6. Neonatal Toxic Erythema
1.2.7. Neonatal acne
1.2.8. Minipuberty in Newborns
1.2.9. Eosinophilic Pustular Folliculitis
1.2.10. Melanosis Pustular Neonatal Transitoria 
1.2.11. Suction Blisters
1.2.12. Seborrheic Dermatitis

1.3. Developmental Abnormalities in the Neonate

1.3.1. Facial Abnormalities
1.3.2. Cervical Abnormalities
1.3.3. Cervical Abnormalities
1.3.4. Cutaneous Indicators of Dysraphism
1.3.5. What to Do When a Newborn Has Developmental Abnormalities?

1.4. Congenital Neonatal Infections

1.4.1. Bacterial Infections
1.4.2. Viral Infections
1.4.3. Fungal Infections

1.5. Erosive  and Blistering Dermatoses

1.5.1. Erosive Dermatoses and Differential Diagnosis
1.5.2. Blistering Dermatoses and Differential Diagnosis

1.6. Neonatal Pathology Associated with Invasive Procedures During Gestation or Childbirth

1.6.1. Cutaneous Manifestations of Invasive Processes During Pregnancy
1.6.2. Cutaneous Manifestations Due to Trauma during Childbirth
1.6.3. Subcutaneous Fat Necrosis and Scleredema of the Newborn

Module 2. Eczematous and Papular desquamative Dermatoses

2.1. Pathophysiology and Clinical Manifestations of Atopic Dermatitis (AD)

2.1.1. Epidemiology of AD
2.1.2. Atopic Gait
2.1.3. AD Pathophysiology
2.1.4. Clinical Manifestations of AD in Different Periods of Childhood and Adolescence
2.1.5. Complications in the Progression of AD

2.2. Update on the Management and Treatment of Atopic Dermatitis

2.2.1. Diagnostic Tests to Be Ordered
2.2.2. Indications for Systemic Allergy Studies
2.2.3. AD Treatment
2.2.4. Management of Patients with Moderate-Severe AD

2.3. Seborrheic Dermatitis

2.3.1. Epidemiology
2.3.2. Clinical Manifestations of Seborrheic Dermatitis in Childhood and Adolescence
2.3.3. Management of Seborrheic Dermatitis

2.4. Irritant and Allergic Contact Dermatitis

2.4.1. Irritant Contact Dermatitis in Infants
2.4.2. Allergic Contact Dermatitis in Childhood

2.5. Pathophysiology and Clinical Manifestations of Psoriasis

2.5.1. Epidemiology of Psoriasis
2.5.2. Pathophysiology of Psoriasis
2.5.3. Clinical Manifestations of Psoriasis in Different Periods of Childhood and Adolescence
2.5.4. Psoriatic Arthropathy

2.6. Management and Treatment of Infantile-Juvenile Psoriasis

2.6.1. Tests to Order
2.6.2. Step Treatment in Psoriasis
2.6.3. Management of Patients with Moderate-Severe Psoriasis

2.7. Pityriasis Rubra Pilaris and Lichen

2.7.1. Pityriasis Rubra
2.7.2. Lichen Planus
2.7.3. Liquen Aureus
2.7.4. Liquen Nitidus

2.8. Pityriasis Lichenoides and Lymphomatoid Papulosis

2.8.1. Pityriasis Lichenoides
2.8.2. Lymphomatoid Papulosis

Module 3. Update in Vascular Pathology

3.1. Infantile Hemangioma

3.1.1. Epidemiology and Pathophysiology
3.1.2. Progression
3.1.3. Clinical Presentation
3.1.4. Complications

3.2. Syndromes Associated to Infantile Hemangioma

3.2.1. PHACE
3.2.2. SACRAL/PELVIS

3.3. Update on the Use of Beta-Blockers in the Treatment of IH
3.4. Congenital Hemangiomas

3.4.1. RICH
3.4.2. NICH

3.5. Other Benign Vascular Tumors

3.5.1. Pyogenic Granuloma
3.5.2. Glomangioma
3.5.3. Verrucous Hemangioma
3.5.4. Spindle Cell Hemangioma
3.5.5. Eruptive Pseudoangiomatosis

3.6. Tumors of Intermediate Malignancy

3.6.1. Tufted Hemangioma
3.6.2. Kaposiform Hemangioendothelioma
3.6.3. Dabska Tumor
3.6.4. Multifocal Lymphangioendotheliomatosis with Thrombocytopenia
3.6.5. Retiform Hemangioendothelioma

3.7. Arteriovenous Malformations

3.7.1. Kaposi’s Sarcoma
3.7.2. Cutaneous Angiosarcoma

3.8. Vascular Malformations Associated with Syndromes I
3.9. Vascular Malformations Associated with Syndromes II 
3.10. Polyarteritis Nodosa, Kawasaki Disease and Takayasu’s Arteritis
3.11. Update on the Treatment and Multidisciplinary Management of the Pediatric Patient with Vascular Malformations

3.11.1. Imaging Tests
3.11.2. Treatment of Vascular Anomalies Excluding IH
3.11.3. Vascular Anomalies Committees 

3.12. Cutaneous Leukocytoclastic Vasculitis, Scholein-Henoch Purpura and Acute Hemorrhagic Edema of Infancy and Urticaria-Vasculitis
3.13. Approach to the Pediatric Patient with Vasculitis
3.14. Malignant Tumours
3.15. Wegener’s Granulomatosis, Churg-Strauss Syndrome, Microscopic Polyangiitis and Cryoglobulinemia
3.16. Capillary, Lymphatic, and Simple Venous Malformations
3.17. Inflammatory and Non-Inflammatory Purpuras

Module 4. Pathology of Skin Appendages

4.1. Alopecia Areata
4.2. Hypertrichosis and Hirsutism
4.3. Non-Scarring Alopecia with Structural Alteration of the Hair
4.4. Nail Alterations

4.4.1. Alterations of the Nail Plate
4.4.2. Alterations of the Nail Bed
4.4.3. Coloration Alterations

4.5. Acne

4.5.1. Pathophysiology and Epidemiology
4.5.2. Types of Acne

4.6. Update on the Management and Treatment of Acne
4.7. Alterations of the Eccrine Glands
4.8. Alterations of the Apocrine Glands
4.9. Scarring Alopecia
4.10. Alterations in Hair Color
4.11. Ectodermal Dysplasias

Module 5. Pigmentary Pathology, Benign and Malignant Tumor Pathology

5.1. Nevus

5.1.1. Melanocytic Nevus
5.1.2. Congenital Melanocytic Nevus
5.1.3. Becker’s Nevus, Nevus Spilus, Halo Nevus
5.1.4. Spitz Nevus
5.1.5. Atypical Nevus and Familial Dysplastic Nevus-Melanoma Syndrome

5.2. Benign Tumors

5.2.1. Epidermal, Sebaceous, Comedonal Nevi and Syndromes
5.2.2. Benign Adnexal Tumors
5.2.3. Dermal, Subcutaneous Cellular Tissue, Muscular, and Benign Bone Tumors

5.3. Intermediate Malignant and Malignant Tumors

5.3.1. Basal Cell Carcinoma and Squamous Cell Carcinoma
5.3.2. Mastocytosis
5.3.3. Cutaneous Lymphomas
5.3.4. Infantile Fibromatosis
5.3.5. Dermatofibrosarcoma Protuberans

5.4. Dermatoses Combining Hypo and Hyperpigmentation and Dermatoses with Hyperpigmentation
5.5. Hypopigmented Dermatoses

5.5.1. Pathologies with Congenital Early Childhood Hypopigmentation
5.5.2. Pathologies with Acquired Hypopigmentation

5.6. Melanoma

Module 6. Infectious Pathology in Pediatric Dermatology 

6.1. Viral Infections I

6.1.1. Herpes Simplex Virus Infection I and II
6.1.2. Varicella Zoster Virus Infection
6.1.3. Non HSV and VZV Herpesvirus Infection

6.2. Viral Infections II

6.2.1. Parvovirus B19 and Enterovirus Infection
6.2.2. Cytomegalovirus and Epstein-Barr Virus Infection
6.2.3. Human Papillomavirus Infection
6.2.4. Poxvirus, Parapoxvirus, and Orthopoxvirus Infection
6.2.5. Viral Exanthem

6.3. Bacterial Infections I

6.3.1. S. Aureus Infections
6.3.2. Streptococcal Infections

6.4. Bacterial Infections II

6.4.1. Infections by Other Gram-Positive Bacteria
6.4.2. Infections by Gram-Negative Bacilli and Cocci
6.4.3. Mycobacterial Infections

6.5. Sexually Transmitted Diseases

6.5.1. Syphilis
6.5.2. Neisseria Gonorrhoeae Infection
6.5.3. Chlamydia Trachomatis Infection
6.5.4. VIH infection
6.5.5. Mandatory Notifiable Diseases: Which Are They and How to Declare Them

6.6. Fungal Infections

6.6.1. Superficial Mycoses
6.6.2. Deep Mycosis

6.7. Protozoal and Helminth Infections

6.7.1. Leishmaniasis
6.7.2. Helminth Infections

6.8. Infestations, Stings and Bites

6.8.1. Arthropod and Insect Bites
6.8.2. Pediculosis and Scabies

Module 7. Genodermatosis 

7.1. Neurofibromatosis (NF) and Tuberous Sclerosis (TS)

7.1.1. Neurofibromatosis
7.1.2. Tuberous Sclerosis

7.2. Update on the Management and New Perspectives in the Treatment of NF and TS
7.3. Other Rasopathies
7.4. Porphyrias
7.5. Genodermatosis with Photosensitivity
7.6. Tumor Syndromes
7.7. Other Genodermatoses
7.8. Non-Syndromic Ichthyosis

7.8.1. Ichthyosis Vulgaris
7.8.2. X-Linked Recessive Ichthyosis
7.8.3. Keratinopathic Ichthyoses
7.8.4. Autosomal Recessive Congenital Ichthyosis (ARCI)

7.9. Syndromic Ichthyosis

7.9.1. Sjögren- Larsson Syndrome
7.9.2. Conradi-Hünermann-Happle Disease
7.9.3. Multiple Sulfatase Deficiency
7.9.4. Refsum Disease
7.9.5. Disease Neutral Lipid Deposition with Ichthyosis
7.9.6. CHILD Syndrome
7.9.7. KID Syndrome
7.9.8. Other Syndromes

7.10. Other Cornification Alterations

7.10.1. Erythrokeratoderma
7.10.2. Porokeratosis
7.10.3. Darier and Haley-Haley Disease
7.10.4. Palmoplantar Keratoderma I
7.10.5. Palmoplantar Keratoderma II

7.11. Main Hereditary Diseases; Diagnostic Process and Genetic Counseling
7.12. Principles of Medical Genetics
7.13. Application of the Whole Genome Array Technique in Pediatric Dermatology
7.14. Optimization of Medical Genetics Resources Applied to Pediatric Dermatology

Module 8. Systemic Pathology with Cutaneous Involvement 

8.1. Dermatomyositis

8.1.1. Microbiological
8.1.2. Treatment
8.1.3. Advances

8.2. Scleroderma

8.2.1. Microbiological
8.2.2. Treatment
8.2.3. Advances

8.3. Other Collagenopathies

8.3.1. Anetoderma
8.3.2. Mixed Connective Tissue Disease
8.3.3. Sjögren’s Syndrome
8.3.4. Relapsing Polychondritis

8.4. Autoinflammatory Diseases

8.4.1. Classification
8.4.2. Microbiological
8.4.3. Treatment
8.4.4. Advances

8.5. Lupus Erythematosus and Antiphospholipid Syndrome

8.5.1. Microbiological
8.5.2. Treatment
8.5.3. Advances

Module 9.  Skin Pathology Due to External Agents and Physical Damage Other  Pathologies

9.1. Cutaneous Signs of Abuse and Mistreatment

9.1.1. Abuse
9.1.2. Abuse

9.2. Cutaneous Pathology Due to External Agents I

9.2.1. Cold
9.2.2. Heat and Pressure
9.2.3. Solar Radiation
9.2.4. Sunburns

9.3. Cutaneous Pathology Due to External Agents II

9.3.1. Photodermatoses: Solar Urticaria, Actinic Prurigo, Polymorphous Light Eruption, Juvenile Spring Eruption, Hydroa Vacciniforme
9.3.2. Toxins, Poisons
9.3.3. Self-Induced Dermatoses: Factitious Dermatitis

9.4. Cutaneous Reactions to Drugs

9.4.1. Toxicodermia
9.4.2. DRESS
9.4.3. TEN/SSJ
9.4.4. Fixed Drug Erythema
9.4.5. Acute Generalized Exanthematous Pustulosis
9.4.6. Other Cutaneous Reactions to Drugs

9.5. Urticaria

9.5.1. On Contact
9.5.2. Physical
9.5.3. Anaphylaxis
9.5.4. Angioedema
9.5.5. Chronic Urticaria

Module 10. New Developments in Diagnostic Imaging Techniques, Laser Treatment and Pediatric Dermatologic Surgery 

10.1. Use of Ultrasound in Pediatric Dermatology

10.1.1. Use of Ultrasound in Inflammatory Pathology
10.1.2. Basic Principles
10.1.3. Clinical Cases 
10.1.4. Role of Ultrasound in the Pediatric Dermatology Consultation
10.1.5. Use of Ultrasound in Tumor Pathology
10.1.6. Clinical Cases

10.2. Laser in the Treatment of Pediatric Dermatological Pathology

10.2.1. Types of Lasers Available and Cost-Effectiveness in a Pediatric Dermatology Consultation
10.2.2. How to Use Lasers on Pediatric Patients?
10.2.3. Indications in Pediatric Dermatology

10.3. Surgical Techniques in Pediatric Dermatology
10.4. Types of Sedation and Anesthesia in Pediatric Surgery

10.4.1. Local Anesthesia
10.4.2. Sedation
10.4.3. General Anesthesia
10.4.4. Controversies in Pediatric Anesthesia

Module 11. Advances in Childhood Blistering Diseases 

11.1. Hereditary Blistering Diseases

11.1.1. Epidermolysis Bullosa Simplex
11.1.2. Junctional Epidermolysis Bullosa
11.1.3. Dystrophic Epidermolysis Bullosa

11.2. Advances in the Management and Treatment of Hereditary HB
11.3. Blistering Autoimmune Diseases I

11.3.1. Bullous Pemphigoid
11.3.2. Bullous Pemphigoid
11.3.3. Chronic Childhood Blistering Disease

11.4. Blistering Autoimmune Diseases II

11.4.1. Epidermolysis Bullosa Acquired
11.4.2. Dermatitis Herpetiformis
11.4.3. Bullous Systemic Lupus Erythematosus

11.5. Management of Immunosuppressant Drugs in Childhood I

11.5.1. Immunosuppressive Drugs
11.5.2. Indications
11.5.3. Management

11.6. Management of Immunosuppressant Drugs in Childhood II

11.6.1. Study of the Patient as a Candidate for Immunosuppressants
11.6.2. Vaccination and Subsequent Management of the Patient Candidate for Immunosuppressants

A unique, key, and decisive training experience to boost your professional development”